SHAREHOLDERS' EQUITY |
9 Months Ended | |||
|---|---|---|---|---|
Sep. 30, 2026 | ||||
| SHAREHOLDERS' EQUITY | ||||
| SHAREHOLDERS' EQUITY | NOTE 4 – SHAREHOLDERS’ EQUITY:
In July 2026, the Company completed a public offering selling 5,750,000 common shares at a price of $20.00 per share, receiving net proceeds of $106.8 million after deducting underwriting discounts and commissions of approximately $8.2 million and other offering expenses. In February 2025, the Company completed a public offering in which it sold 3,105,000 shares of common stock at $5.00 per share, receiving net proceeds of $14.0 million after deducting underwriting discounts and commissions of $1.1 million and other offering expenses of $0.4 million. In February 2022, the Company granted to the underwriter of the IPO 128,000 fully vested warrants upon the IPO, exercisable into common shares with an exercise price of $6.25 per share for 5 years after the grant date. The 128,000 fully vested warrants had an estimated value (based on Black-Scholes model) of approximately $458,000 and were recognized as a reduction from gross proceeds of the IPO. Prior to December 31, 2025, IPO warrants totaling 105,920 were exercised for $0.7 million. As of September 30, 2026, the final IPO warrants totaling 22,080 were exercised for $0.1 million. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|